scholarly journals Long term effect of spa therapy combined with patient education program on subjects with overweight and obesity — A controlled study

2019 ◽  
Vol 13 (5) ◽  
pp. 492-498 ◽  
Author(s):  
Coralie Schnebelen-Berthier ◽  
Nathalie Negro ◽  
Arnaud Jaruga ◽  
Christian-François Roques ◽  
Jean-Michel Lecerf
PEDIATRICS ◽  
1993 ◽  
Vol 91 (6) ◽  
pp. 1121-1126 ◽  
Author(s):  
Peter J.F.M. Merkus ◽  
Philip H. Quanjer ◽  
Elisabeth E.M. van Essen-Zandvliet ◽  
Karel F. Kerrebijn ◽  
Eric J. Duiverman ◽  
...  

Background. Growth in stature in asthmatic adolescents may be delayed compared to normals as a result of treatment with inhaled corticosteroids (CS) or because of a delay in puberty. However, growth rates in asthmatic children have never been studied when treatment with CS was randomized and when growth was compared with that of matched healthy control subjects. Objective. To assess the long-term effect of CS treatment on growth rates in asthmatic adolescents. Methods. Participants were 40 asthmatic teenagers (mean age 12.8 years) who received randomized treatment with 0.2 mg of albuterol (salbutamol) with either placebo three times a day (BA + PL) or 0.2 mg of budesonide three times a day (BA + CS) for a median period of 22 months in a double-blind controlled study. Growth rates were compared with those of 80 control subjects who were matched for sex, age, height, and duration of follow-up. Results. Growth rates in male patients, but not in female patients, were significantly less than in control subjects (P < .05), a finding consistent with a delay of puberty due to asthma. The mean difference (95% confidence interval) in growth rates between patients treated with BA + PL and their controls was -0.70 (–1.62, 0.22) cm/y; that between patients treated with BA + CS and their controls was -0.44 (–1.25, 0.37) cm/y. The observed mean (SEM) case-control difference between treatment groups was + 0.27 (0.58) cm/y in favor of BA + CS. Conclusion. Growth retardation observed in adolescents with asthma may be due to a delay in puberty but not to the prescription of 0.6 mg of budesonide daily.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Xiaoxian Zhang ◽  
Zhengdao Lai ◽  
Rihuang Qiu ◽  
E Guo ◽  
Jing Li ◽  
...  

Abstract Background Severe asthma is difficult to control. Therapeutic patient education enables patients to better understand their disease and cope with treatment, but the effect of therapeutic patient education in severe uncontrolled asthma is unclear. We evaluated whether therapeutic patient education is effective in improving asthma control and decreasing the frequency of exacerbations in severe uncontrolled asthma. Methods This was a prospective, observational, and self-controlled study that enrolled 40 subjects with severe uncontrolled asthma. Patients were seen at a clinic four times (on day 1 and after 3, 6, and 12 months). After baseline data collection, the subjects completed a therapeutic patient education program and were also followed-up via telephone after 1, 2, 4, 5, 7, 8, 9, 10, and 11 months to monitor asthma medication adherence and collect asthma-related information. Results Within the 1-year study period, a total of 23 exacerbations were recorded in 14 patients, seven of whom required emergency treatment and two of whom were hospitalized. Twelve months after the standardized therapeutic patient education program, pulmonary function and fractional exhaled nitric oxide levels improved significantly in all 40 patients. Moreover, the scores from three standardized asthma questionnaires and indices suggested improved quality of life in these patients with severe uncontrolled asthma. Serum levels of biomarkers reflecting asthma immune responses did not change between baseline and the 1-year follow-up time point. Conclusions Therapeutic patient education is effective in improving asthma control and decreasing exacerbations in patients with severe uncontrolled asthma.


Diabetes Care ◽  
2010 ◽  
Vol 33 (3) ◽  
pp. e36-e36 ◽  
Author(s):  
N. Hermanns ◽  
B. Kulzer ◽  
M. Krichbaum ◽  
T. Kubiak ◽  
T. Haak

2010 ◽  
Vol 19 (1) ◽  
pp. 133-137 ◽  
Author(s):  
Arrigo F.G. Cicero ◽  
Ada Dormi ◽  
Sergio D'Addato ◽  
Antonio V. Gaddi ◽  
Claudio Borghi

Rheumatology ◽  
1994 ◽  
Vol 33 (2) ◽  
pp. 148-151 ◽  
Author(s):  
F. GUILLEMIN ◽  
F. CONSTANT ◽  
J. F. COLLIN ◽  
M. BOULANGE

Sign in / Sign up

Export Citation Format

Share Document